IDEXX Laboratories, Inc. (IDXX) vs Medline Inc. (MDLN)

A side-by-side comparison of IDEXX Laboratories, Inc. and Medline Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 29, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total returnIDXX vs MDLN

growth of $100 · dividends reinvested · last 1y
IDXX -19.1%MDLN -1.2%MDLN compounded faster
8090100110120Start $1002026$81$99
IDXX MDLN

IDXX vs MDLN: by the numbers

  • IDXX is the larger company ($44.95B vs $33.89B market cap).
  • MDLN trades at the lower trailing earnings multiple (33.48 vs 42.00 P/E), one valuation lens rather than an overall verdict.
  • IDXX converts more revenue to profit (24.63% vs 3.31% net margin).

Metrics side by side

Valuation

MetricIDXXMDLN
P/E ratio42.0033.48
Forward P/E38.8926.74
P/S ratio10.331.15
P/B ratio29.532.96
PEG ratio2.31N/A
EV / EBITDA30.1314.69
FCF yield2.35%4.56%

Profitability

MetricIDXXMDLN
Gross margin62.05%24.04%
Operating margin31.63%7.04%
Net margin24.63%3.31%
ROE70.38%8.55%
ROIC40.27%5.69%

Growth (annualized)

MetricIDXXMDLN
Revenue CAGR (5Y)9.24%N/A
EPS CAGR (5Y)14.07%N/A
FCF CAGR (5Y)10.13%N/A
Total return CAGR (5Y)-3.92%N/A

Frequently asked

Which has the lower trailing P/E, IDXX or MDLN?
MDLN has the lower trailing P/E: IDXX trades at 42.00 and MDLN at 33.48. P/E is one valuation measure and does not by itself establish which business is cheaper.
Is IDXX or MDLN more profitable?
IDXX runs the higher net margin — IDXX at 24.63% versus MDLN at 3.31%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 29, 2026.